BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 21305450)

  • 21. Incidence of skin lymphoma in Germany.
    Stang A; Streller B; Katalinic A; Lehnert M; Eisinger B; Kaatsch P; Jöckel KH
    Ann Epidemiol; 2006 Mar; 16(3):214-22. PubMed ID: 16019225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The incidence and mortality of cutaneous melanoma in Southern Germany: trends by anatomic site and pathologic characteristics, 1976 to 2003.
    Lasithiotakis KG; Leiter U; Gorkievicz R; Eigentler T; Breuninger H; Metzler G; Strobel W; Garbe C
    Cancer; 2006 Sep; 107(6):1331-9. PubMed ID: 16909413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Skin cancer rates in North Rhine-Westphalia, Germany before and after the introduction of the nationwide skin cancer screening program (2000-2015).
    Stang A; Jöckel KH; Heidinger O
    Eur J Epidemiol; 2018 Mar; 33(3):303-312. PubMed ID: 29294207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Screening for and early detection of skin melanoma in the Netherlands].
    van Roekel EH; Verbeek AL; Bonenkamp H
    Ned Tijdschr Geneeskd; 2012; 156(26):A4456. PubMed ID: 22759708
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Are all melanomas dangerous?
    Nørgaard C; Glud M; Gniadecki R
    Acta Derm Venereol; 2011 Sep; 91(5):499-503. PubMed ID: 21874217
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Melanoma mortality following skin cancer screening in Germany.
    Boniol M; Autier P; Gandini S
    BMJ Open; 2015 Sep; 5(9):e008158. PubMed ID: 26373399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reducing mortality in individuals at high risk for advanced melanoma through education and screening.
    Geller AC; Swetter SM; Oliveria S; Dusza S; Halpern AC
    J Am Acad Dermatol; 2011 Nov; 65(5 Suppl 1):S87-94. PubMed ID: 22018072
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Target: melanoma: skin cancer screenings hold promise to reduce mortality rates, but usage of widespread screening lags.
    Printz C
    Cancer; 2013 Jul; 119(13):2359-60. PubMed ID: 23775430
    [No Abstract]   [Full Text] [Related]  

  • 29. Interstate differences in incidence and mortality from melanoma. A re-examination of the latitudinal gradient.
    Jones ME; Shugg D; Dwyer T; Young B; Bonett A
    Med J Aust; 1992 Sep; 157(6):373-8. PubMed ID: 1447984
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The control of melanoma in New Zealand.
    Sneyd M; Cox B
    N Z Med J; 2006 Sep; 119(1242):U2169. PubMed ID: 16998570
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors related to the presentation of thin and thick nodular melanoma from a population-based cancer registry in Queensland Australia.
    Geller AC; Elwood M; Swetter SM; Brooks DR; Aitken J; Youl PH; Demierre MF; Baade PD
    Cancer; 2009 Mar; 115(6):1318-27. PubMed ID: 19189368
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cutaneous melanoma: public health approach to early detection.
    Weinstock MA
    Dermatol Ther; 2006; 19(1):26-31. PubMed ID: 16405567
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Melanoma in HIV patients: 14 cases].
    Qasmi S; Sutra-Loubet C; Maubec E; Boitier F; Duvillard P; Carlotti A; Marinho E; Jacobelli S; Franck N; Gorin I; Vacher-Lavenu MC; Bouscarat F; Crickx B; Dupin N; Avril MF
    Ann Dermatol Venereol; 2010 Dec; 137(12):769-74. PubMed ID: 21134578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Observed and expected mortality in the German skin cancer screening pilot project SCREEN.
    Eisemann N; Waldmann A; Holleczek B; Katalinic A
    J Med Screen; 2018 Sep; 25(3):166-168. PubMed ID: 29169295
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The strategy of prevention and early detection of cutaneous melanoma].
    Vereecken P; Laporte M; De Donder B; Van Staey A; Boonen H; Heenen M; Snauwaert JE
    Rev Med Brux; 2006 Sep; 27(4):S233-8. PubMed ID: 17091884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness of skin cancer screening for individuals age 14 to 34 years.
    Schmitt J; Seidler A; Heinisch G; Sebastian G
    J Dtsch Dermatol Ges; 2011 Aug; 9(8):608-16. PubMed ID: 21501381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved survival for melanoma in Northern Ireland: a comparison of two 5-year periods (1984-88 and 1994-98).
    McMullen EA; Kee F; Patterson CC; Gavin AT; Dolan OM
    Br J Dermatol; 2004 Sep; 151(3):587-93. PubMed ID: 15377344
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence and mortality of malignant melanoma in Berlin (West) from 1980 to 1986.
    Garbe C; Thiess S; Nürnberger F; Ehlers G; Albrecht G; Lindlar F; Bertz J
    Acta Derm Venereol; 1991; 71(6):506-11. PubMed ID: 1685833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thick melanoma: the problem continues.
    Tejera-Vaquerizo A; Mendiola-Fernández M; Fernández-Orland A; Herrera-Ceballos E
    J Eur Acad Dermatol Venereol; 2008 May; 22(5):575-9. PubMed ID: 18081751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early detection of thick melanomas in the United States: beware of the nodular subtype.
    Demierre MF; Chung C; Miller DR; Geller AC
    Arch Dermatol; 2005 Jun; 141(6):745-50. PubMed ID: 15967921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.